The heterogeneous phenotypes among patients with coronavirus disease 2019 (COVID-19)
has drawn worldwide attention, especially those with severe symptoms without comorbid …

The characterization of cell‐mediated and humoral adaptive immune responses to SARS‐
CoV‐2 is fundamental to understand COVID‐19 progression and the development of …

Beyond the acute illness caused by severe acute respiratory coronavirus 2 (SARS-CoV-2)
infection, about one-fifth of infections result in long-term persistence of symptoms despite the …

The coronavirus disease-19 pandemic (COVID-19), which appeared in China in December
2019 and rapidly spread throughout the world, has forced clinicians and scientists to take up …

Severe infection with severe acute respiratory syndrome coronavirus (SARS-CoV)-2 is
characterized by massive cytokine release and T cell loss. The exaggerated host immune …

SARS-CoV-2 causes a spectrum of COVID-19 disease, the immunological basis of which
remains ill defined. We analyzed 85 SARS-CoV-2-infected individuals at acute and/or …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a new member of the
coronavirus family that can cause coronavirus disease 2019 (COVID‐19). COVID‐9 has …

COVID-19, caused by the SARS-CoV-2 virus, has become pandemic. With sharply rising
infection rates, patient groups characterized by an enhanced infection risk will be …

Highlights•Post-acute sequelae of SARS-CoV-2 (PASC) are associated with persistent
inflammation.•The antigens or other immune stimuli driving PASC are still unclear.•PASC …

Abstract Coronavirus disease (COVID-19) is a viral infectious disease caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. The infection was reported in …